Clinical Trials Logo

Acne clinical trials

View clinical trials related to Acne.

Filter by:

NCT ID: NCT01948570 Completed - Acne Clinical Trials

Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment

ANTI-ACNE
Start date: March 2013
Phase: N/A
Study type: Observational [Patient Registry]

Primary end point of the study is the clinical and non-invasive instrumental evaluation of the activity of P-3075 cream on subjects with acne: 20 subjects with a mild/moderate grade and 20 subjects with a moderately severe/severe grade, according to Cunliffe' classification. Secondary end-points are the cosmetic acceptability and efficacy evaluation by the volunteers and the local tolerability assessed by the investigator and the subjects.

NCT ID: NCT01929057 Completed - Acne Clinical Trials

Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris

Start date: August 2013
Phase:
Study type: Observational

The purpose of this study is to determine the response of acne patients and healthy control patients to the P. acnes bacteria. Half a tube of blood will be drawn from all participants to determine whether or not they have antibodies to the P. acnes bacterium. Anywhere from 1 to 4 skin biopsies of acne pimples or normal control skin will be taken from all subjects for further analysis in the lab to determine whether the inflammation in these pimples can be reduced using anti-P.acnes antibodies.

NCT ID: NCT01857960 Recruiting - Acne Clinical Trials

Attitudes and Knowledge of Acne in Mexican Adolescents

Start date: May 2012
Phase: N/A
Study type: Observational

Acne is a chronic inflammatory disease that affects almost 100% of the teenagers worldwide. The peak incidence is between 12 and 18 years old, although it can be present in adults. There are many different beliefs about what can cause or exacerbate acne, and also about treatment. In Mexico, 26.4% of the population is between 15 and 29 years old, which represents that more than 25% of the population is at risk for presenting acne. In our country, the different beliefs about the causes and treatment of acne among general adolescent population have not been explored. The objective of the present study is to determine the possible causes for which young Mexicans do not go to the dermatologist to receive treatment for acne. Our main hypothesis is that the lack of knowledge of the disease is responsible for this behavior.

NCT ID: NCT01850095 Recruiting - Quality of Life Clinical Trials

The Influence of Peripheral Androgen Conversion at Women Adult Acne

Start date: March 2012
Phase: N/A
Study type: Interventional

Acne vulgaris is a chronic inflammatory disease that affects the pilosebaceous unit. Recent studies have demonstrated an increase number of acne cases in adult women. These cases are predominantly normoandrogenic and have some clinical differences when compared with the most common group, the adolescent. The local glandular metabolism converts some hormonal precursors to more active substances that increase the sebum production, leaving these areas more prone to increase the colonization to Propionibacterium Acnes (P. Acnes). Toll-like receptor 2, expressed by inflammatory cells play a crucial role in the innate immune response to this bacterium. Previous studies confirm that exist a reduced expression of CD1d by keratinocytes in acne lesion, what can be interpreted as a low antigen-present function. The influence of hormonal alteration in the sebaceous glands could modulate the expressions of TLR-2 and CD1d explaining the persistence of lesions in adult women. The change to more estrogenic metabolism, with use of specific contraceptive pills could normalize this immune-mediated inflammatory process. Objective To analyze how the peripheral androgen conversion can influence the toll-like receptor 2 and CD1d expression in women with inflammatory acne before and after 6 months of oral contraceptives with anti-androgen activity.

NCT ID: NCT01835210 Completed - Quality of Life Clinical Trials

Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life

Start date: August 2012
Phase: N/A
Study type: Observational

Acne vulgaris is a common problem in the adolescent community. Past research has shown that acne affects teenager's self-esteem and mood. However, no research has evaluated the parent perception of their teenager's acne in comparison to the severity of acne and the patient's own reported quality of life. It is hypothesized that parents of teenagers underestimate how much acne vulgaris affects their teenager's skin disease-related quality of life. Also that teenager's perception of the severity of their acne is greater versus their parent's perception. We believe that increased acne severity based on clinician assessment will correlate with worse quality of life. Teenagers between 12 and 17 years old with a diagnosis of acne by a pediatric dermatologist will be enrolled in this study. The study consists of 1 visit, questions regarding demographics, assessment of the teen's acne, the Skindex-Teen quality of life survey (modified for parents), and 2 Likert scales will be completed. In addition, the clinician will score the teen's acne using the standardized Investigator Global Assessment tool. Statistical analysis will compare teen subject answers to the Skindex-Teen with their parent's answers. Also analyzed will be the severity of acne and differences between the clinician IGA score and Skindex-Teen responses

NCT ID: NCT01796665 Completed - Acne Clinical Trials

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Start date: February 2012
Phase: Phase 3
Study type: Interventional

The objective of this study was to evaluate the efficacy and safety of Perrigo's test formulation of Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% compared to the already marketed formulation, Acanya gel in patients with acne vulgaris.

NCT ID: NCT01764308 Terminated - Acne Clinical Trials

Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

Omega-3
Start date: January 2013
Phase: Phase 3
Study type: Interventional

60 patients receiving isotretinoin will be recruited from the UCLA acne specialty clinic. Subjects will be randomized in a 1:1 ratio to receive placebo or omega-3 1200mg twice a day for 24 weeks.

NCT ID: NCT01701024 Completed - Acne Clinical Trials

Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

ACYC
Start date: October 2012
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.

NCT ID: NCT01688531 Completed - Acne Clinical Trials

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Start date: August 2012
Phase: Phase 1
Study type: Interventional

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

NCT ID: NCT01657110 Completed - Acne Clinical Trials

Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne

Start date: December 2012
Phase: Phase 2
Study type: Interventional

Mild to moderate facial acne is an extremely common disease of teenagers and young adults. This pilot study will investigate whether treatment with a gel containing tea tree oil reduces numbers of acne lesions and improves acne in twenty otherwise healthy consenting participants. The hypothesis is that treatment with tea tree oil gel will result in a significant improvement in acne after 12 weeks of treatment.